Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders

Clinical trial NCT01372228 · TERMINATED

Trial details

NCT number: NCT01372228
Sponsor: Talaris Therapeutics Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hurler Syndrome (MPS I)Hurler-Scheie Syndrome Hunter Syndrome (MPS II)Sanfilippo Syndrome (MPS III)Krabbe Disease (Globoid Leukodystrophy)Metachromatic Leukodystrophy (MLD)Adrenoleukodystrophy (ALD and AMN)Sandhoff Disease Tay Sachs Disease Pelizaeus Merzbacher (PMD)Niemann-Pick Disease Alpha-mannosidosis

Start date: 2011-04-01
Primary completion: 2016-04-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.